Chronic Rhinosinusitis Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You have been diagnosed with chronic rhinosinusitis (a long-term sinus condition) based on specific recognised medical guidelines, with symptoms lasting at least 12 weeks in a row.
- Your sinus condition shows signs of inflammation, such as discoloured nasal discharge, nasal polyps, swelling, or redness inside the nose — confirmed by a doctor's examination or a CT scan.
- You are 19 years of age or older and weigh at least 50 kg (about 110 lbs).
- You are physically able to do a specific nasal test used in the study (confirm with trial site).
- If you are a woman who could become pregnant, you must have a negative pregnancy test before joining.
- You are willing and able to give written consent to take part.
Who may not be able to join:
- You have had an acute (sudden) illness within the 2 weeks before the study begins.
- You have had a major asthma attack within the 2 months before the study begins.
- You have changed any nasal medications (such as nasal steroids or certain nasal sprays) within 14 days before the study begins.
- You have tested positive for Hepatitis B, Hepatitis C, or HIV.
- Your blood tests show low haemoglobin (a measure of red blood cells) or low albumin (a protein in your blood).
- Your liver function blood tests show results that are significantly above the normal range.
- Your kidney function blood tests show results that are significantly above the normal range.
- You are currently pregnant or breastfeeding.
- You have previously had an organ transplant or a bone marrow/blood cell transplant.
- You have a history of an autoimmune disease or a granulomatous disorder (a type of inflammatory disease) (confirm with trial site).
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Brad Woodworth, MD, University of Alabama at Birmingham
Phone: (205) 975-6169
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Measurable Difference in CFTR function
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.